Titre:
  • Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules.
Auteur:Awada, Ahmad; Giacchetti, S; Gérard, B.; Eftekhary, P; Lucas, Catherine; De Valeriola, Dominique; Poullain, M G; Soudon, J; Dosquet, C; Brillanceau, M-H; Giroux, B; Marty, Marianne; Bleiberg, Harry; Calvo, F; Piccart-Gebhart, Martine
Informations sur la publication:Annals of oncology, 13, 12, page (1925-1934)
Statut de publication:Publié, 2002-12
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Aged
Biological Availability
Carbazoles -- administration & dosage
Carbazoles -- adverse effects
Carbazoles -- pharmacokinetics
Dose-Response Relationship, Drug
Drug Administration Schedule
Ellipticines
Female
Follow-Up Studies
Humans
Infusions, Intravenous
Male
Maximum Tolerated Dose
Middle Aged
Neoplasms -- drug therapy
Neoplasms -- pathology
Pyridines -- administration & dosage
Pyridines -- adverse effects
Pyridines -- pharmacokinetics
Risk Assessment
Sensitivity and Specificity
Treatment Outcome
Note générale:Clinical Trial
Clinical Trial, Phase I
Journal Article
Multicenter Study
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:pmid/12453862